Markets News, January 17, 2025: Stocks Surge as Big-Tech Rallies; S&P 500 Has Best Week in Two Months; Bitcoin Tops $105,000 ...

Perfect Repair: Metal glue is a high strength epoxy adhesive used as an alternative to torch welding, providing strong and durable repairs to metal and several other surfaces, forming a strong and ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Disclaimer Statement: This content is authored by a 3rd party. The views expressed here are that of the respective authors/ entities and do not represent the views of Economic Times (ET). ET does not ...

Get Pro-Level Earnings Insights Before the Market Moves Goldman Sachs: The pullback in ServiceTitan's stock during Monday's after-hours trading reflects "investors' expectation for greater upside ...

Shondah and Randall Otwell are ranchers in northeastern Wyoming who recently patented a new way to keep water from freezing in stock water tanks. Shondah is fourth-generation on this family ranch ...

The revised price target implies a potential upside of 16% from Friday’s closing levels of LTIMindtree. The stock has corrected nearly 15% from its record high level of ₹6,767.95, which the stock had ...

Customers will be pushed towards buying models that are more expensive or lean on non-instantaneous storage tank water heaters, which are generally cheaper but tend to be less efficient than the ...

Stock market today: BSE Sensex and Nifty50 declined nearly 1 per cent on Friday as investors reduced their holdings in banking and IT sectors before the upcoming earnings season.

The bears took control of Dalal Street on Friday, pushing Nifty close to the critical 24,000 level after strong gains in the first two sessions of the new year. The decline was driven by selling ...

Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some ...

Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged. The biopharmaceutical firm's navacaprant treatment failed to reach both primary and ...